ELMSFORD, N.Y (AP) -- Pharmacy benefits manager BioScrip Inc. said Thursday that it will pay $70 million in cash to acquire HomeChoice, a company that offers non-hospital drug infusion services.
HomeChoice is a subsidiary of DaVita HealthCare Partners, which operates more than 1,900 dialysis centers across the U.S.
Headquartered in Norfolk, Va., HomeChoice has 14 infusion pharmacy locations in the Mid-Atlantic and Southern U.S.
BioScrip expects the transaction to close in the first quarter of 2013. The company estimates HomeChoice will generate $70 million in annual revenue after integration.
BioScrip Inc. shares rose 23 cents, or 2.15 percent, to $10.94 in trading Thursday.
Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.
SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.
All contents herein copyright San Diego Source ® 1994-2015